Japan drugmakers feeling the heat from copycats
Many emerging nations fail to protect IP rights
Tokyo
JAPAN's pharmaceutical companies are struggling to do business in emerging nations due to the proliferation of copycat drugs, with a Chinese firm allegedly making a drug for Ebola that Fujifilm Holdings Corp says infringes on its intellectual property rights.
Fujifilm plans to file a lawsuit against Sihuan Pharmaceutical Holdings Group to suspend production of a copycat of Avigan, whose patent is held by Fujifilm. But some emerging nations are not making active efforts to protect intellectual property rights.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Holiday Inn owner IHG’s Q1 revenue up 2.6%, leisure travel demand remains strong
WSJ moves Asia headquarters from Hong Kong to Singapore
South Korea to slap fines on food suppliers for ‘shrinkflation’
Olam outbids Dreyfus’ sweetened deal for Australia’s Namoi, raises offer to A$0.66 per share
Live Nation’s revenue beats estimates as boom in concerts drive ticket sales
Jim Beam owner bets on canned vodka cocktails to double revenue